Literature DB >> 34356636

Inflammation and Cell Death of the Innate and Adaptive Immune System during Sepsis.

Christina Nedeva1.   

Abstract

Sepsis is a life-threatening medical condition that occurs when the host has an uncontrolled or abnormal immune response to overwhelming infection. It is now widely accepted that sepsis occurs in two concurrent phases, which consist of an initial immune activation phase followed by a chronic immunosuppressive phase, leading to immune cell death. Depending on the severity of the disease and the pathogen involved, the hosts immune system may not fully recover, leading to ongoing complications proceeding the initial infection. As such, sepsis remains one of the leading causes of morbidity and mortality world-wide, with treatment options limited to general treatment in intensive care units (ICU). Lack of specific treatments available for sepsis is mostly due to our limited knowledge of the immuno-physiology associated with the disease. This review will provide a comprehensive overview of the mechanisms and cell types involved in eliciting infection-induced immune activation from both the innate and adaptive immune system during sepsis. In addition, the mechanisms leading to immune cell death following hyperactivation of immune cells will be explored. The evaluation and better understanding of the cellular and systemic responses leading to disease onset could eventuate into the development of much needed therapies to combat this unrelenting disease.

Entities:  

Keywords:  cell death; immune activation; infection; inflammation; sepsis

Year:  2021        PMID: 34356636     DOI: 10.3390/biom11071011

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  8 in total

Review 1.  Cardiomyocyte death in sepsis: Mechanisms and regulation (Review).

Authors:  Geping Zhang; Dan Dong; Xianyao Wan; Yongli Zhang
Journal:  Mol Med Rep       Date:  2022-06-15       Impact factor: 3.423

2.  Blood Bacteria-Free DNA in Septic Mice Enhances LPS-Induced Inflammation in Mice through Macrophage Response.

Authors:  Warerat Kaewduangduen; Peerapat Visitchanakun; Wilasinee Saisorn; Ariya Phawadee; Charintorn Manonitnantawat; Chirapas Chutimaskul; Paweena Susantitaphong; Patcharee Ritprajak; Naraporn Somboonna; Thanya Cheibchalard; Dhammika Leshan Wannigama; Patipark Kueanjinda; Asada Leelahavanichkul
Journal:  Int J Mol Sci       Date:  2022-02-08       Impact factor: 5.923

3.  Identification of Hub Genes With Differential Correlations in Sepsis.

Authors:  Lulu Sheng; Yiqing Tong; Yi Zhang; Qiming Feng
Journal:  Front Genet       Date:  2022-03-24       Impact factor: 4.599

4.  Identification of Immune-Related Key Genes as Potential Diagnostic Biomarkers of Sepsis in Children.

Authors:  Huabin Wang; Junbin Huang; Wenfang Yi; Jiahong Li; Nannan He; Liangliang Kang; Zhijie He; Chun Chen
Journal:  J Inflamm Res       Date:  2022-04-14

5.  Curcumin Elevates microRNA-183-5p via Cathepsin B-Mediated Phosphatidylinositol 3-Kinase/AKT Pathway to Strengthen Lipopolysaccharide-Stimulated Immune Function of Sepsis Mice.

Authors:  Yanan Liu; LiZhi Feng; Guo Hou; Lan Yao
Journal:  Contrast Media Mol Imaging       Date:  2022-07-30       Impact factor: 3.009

6.  Effects of different doses of methylprednisolone therapy on acute respiratory distress syndrome: results from animal and clinical studies.

Authors:  Shukun Hong; Chao Jian; Hongye Wang; Xincheng Wang; Luchuan Xing; Lujun Qiao
Journal:  BMC Pulm Med       Date:  2022-09-16       Impact factor: 3.320

7.  Dysregulated autophagy-related genes in septic cardiomyopathy: Comprehensive bioinformatics analysis based on the human transcriptomes and experimental validation.

Authors:  Hua-Xi Zou; Bai-Quan Qiu; Ze-Yu Zhang; Tie Hu; Li Wan; Ji-Chun Liu; Huang Huang; Song-Qing Lai
Journal:  Front Cardiovasc Med       Date:  2022-08-02

8.  Significant difference of differential expression pyroptosis-related genes and their correlations with infiltrated immune cells in sepsis.

Authors:  Li Wang; Jiting Zhang; Li Zhang; Lingli Hu; Jianhui Tian
Journal:  Front Cell Infect Microbiol       Date:  2022-09-29       Impact factor: 6.073

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.